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a  b  s  t  r  a  c  t
There  is  substantial  evidence  that  research  studies  reported  in
the  scientific  literature  do not  provide  adequate  information  so
that  readers  know  exactly  what  was  done  and  what  was  found.
This  problem  has  been  addressed  by the development  of  reporting
guidelines which  tell  authors  what  should  be  reported  and  how  it
should  be described.  Many  reporting  guidelines  are  now  available
for  different  types  of  research  designs.  There  is  no  such  guideline
for one type  of  research  design  commonly  used  in the  behavioral
sciences,  the  single-case  experimental  design  (SCED).  The  present
study  addressed  this  gap.  This  report  describes  the  Single-Case
Reporting  guideline  In  BEhavioural  interventions  (SCRIBE)  2016,
 This article is a reprint of a previously published article. For citation purposes, please use the original publication details:
Archives of Scientific Psychology 2016, 4, 10–31, DOI: https://doi.org/10.1037/arc0000027.
https://doi.org/10.1016/j.prps.2019.03.001
1269-1763/© 2019 Published by Elsevier Masson SAS on behalf of Socie´te´ Franc¸ aise de Psychologie. This is an open access article
under  the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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which  is a set  of 26  items  that  authors  need  to address  when  writing
about  SCED  research  for publication  in  a scientific  journal.  Each  item
is  described,  a rationale  for its inclusion  is provided,  and  examples
of  adequate  reporting  taken  from  the  literature  are  quoted.  It  is
recommended  that  the  SCRIBE  2016  is  used  by authors  preparing
manuscripts  describing  SCED  research  for publication,  as  well  as
journal  reviewers  and  editors  who  are  evaluating  such  manuscripts.
©  2019  Published  by  Elsevier  Masson  SAS  on  behalf  of  Socie´te´
Franc¸aise  de  Psychologie.  This  is an  open  access  article  under  the
CC BY  license  (http://creativecommons.org/licenses/by/4.0/).
S  c  i e  n  t  i f  i c  a  b  s  t  r  a  c  t
Single-case  experimental  design  (SCED)  studies  in  the  behavioral
sciences  literature  are  not  only  common,  but  their  proportion
has also  increased  over  past  decades.  Moreover,  methodological
complexity of  SCEDs  and  sophistication  in  the  techniques  used
to  analyze  SCED  data  has  increased  apace.  Yet recent  reviews  of
the  behavioral  sciences  literature  have  shown  that  reporting  of
SCED  research  is  highly  variable  and  often  incomplete.  Explicit,
precise  and  transparent  reporting  is crucial  not  only  for critical
evaluation  of the  study  methodology  and  conclusions,  but  also  to
facilitate  exact  replication  of  investigations,  and  ascertain  applica-
bility  and  possible  generality  of results.  Accord-  ingly,  we  developed
the  SCRIBE  2016  (Single-Case  Reporting  guideline  In BEhavioural
interventions)  by  a  consensus  process  by  experts  in SCED  method-
ology and  research  in the  behavioral  sciences,  as  well  as  experts
in  reporting  guideline  development.  The  SCRIBE  2016  Explanation
and Elaboration  article  describes  a set of  26  items  to  guide  and
structure  the  reporting  of  SCED  research.  A  rationale  and  mini-
mum  reporting  standards  that stipulate  what  needs  to be  reported
are  provided  for each  item.  In addition,  examples  of  adequate  and
clear  reporting  drawn  from  the  literature  are  included  for each
item.  It  is  recommended  that  the  SCRIBE  2016  Explanation  and
Elaboration  article  is  used  in conjunction  with  the complemen-
tary SCRIBE  2016  Statement  (Tate  et  al.,  2016) by  authors  preparing
manuscripts  for  publication  and  journal  reviewers  and  editors  con-
sidering  manuscripts  for publication.
© 2019  Published  by  Elsevier  Masson  SAS  on  behalf  of  Socie´te´
Franc¸ aise  de  Psychologie.  This  is an  open  access  article  under  the
CC BY  license  (http://creativecommons.org/licenses/by/4.0/).
Essentially, without publication, the research remains invisible to the
world. And yet, too often, reading these articles leaves us unable to determine exactly how the
research was conducted, what was found, how reliable the findings are and how they fit into
the wider context of existing knowledge. Many published articles are not fit for purpose.
(Simera, Moher, Hoey, Schulz, & Altman, 2010, p. 35)
Single-case experimental designs (SCEDs) are used frequently in the behavioral sciences. Shadish
and Sullivan (2011) surveyed the contents of 21 journals in psychology and education for the calen-
dar year 2008 and found that 44% of intervention studies used single-case methods. Similarly, 39% of
records archived on the PsycBITE evidence database (www.psycbite.com), representing all published
nonpharmacological interventions for psychological consequences of acquired brain impairment,
used single-case methods (Perdices et al., 2006). This result is comparable to Beeson and Robey’s
(2006) findings for the specific domain of aphasiology (41%). Both Hammond and Gast (2010) and
Maggin, O’Keeffe, and Johnson (2011) demonstrated an accelerating trend for an increased number of
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single-case reports published over recent decades. SCEDs are also used in medicine (Gabler, Duan,
Vohra, & Kravitz, 2011), where they are specifically referred to as N-of-1 trials. This variety of SCED
consists of multiple cross-overs (or phase changes) using the withdrawal A-B-A-B paradigm in a single
participant who serves as his or her own control, often incorporating randomization and/or blinding
(Kravitz, Duan, & the DEcIDE Methods Center N-of-1 Guidance Panel, 2014). Well- designed and con-
ducted SCEDs provide a strong level of evidence, and in particular the randomized N-of-1 trial provides
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Fig. 1. Common designs in the literature using a single participant. Reproduced from the expanded manual for the Risk of Bias
in  N-of-1 Trials (RoBiNT) Scale (Tate et al., 2015) with permission of the authors; an earlier version of the figure, taken from the
original RoBiNT Scale manual (Tate et al., 2013a), was  also published in 2013 (Tate et al., 2013b).
St Leonards NSW 2065, Australia. E-mail: robyn.tate@sydney.edu.au evidence1 for treatment decision
purposes (Guyatt, Jaeschke, & McGinn, 2002; OCEBM, 2011).
Designs using single-case methods can be complex and sophisticated (e.g., a combination of
a multiple-baseline with alternating-treatments design, this particular method comprising 10% of
designs in the Shadish and Sullivan (2011) survey). Recently, a class of single-case designs has been
proposed that involves a variety of randomization procedures and can increase the internal validity of
these designs (Kratochwill & Levin, 2010), as well as provide options for data analysis (see Kratochwill
& Levin, 2014). The range of single-case designs, however, is a potential source of misunderstanding
because not all reports in the literature that study a single participant also apply single-case method-
ology, as de- fined2. Fig. 1 depicts the common designs using a single-participant as reported in the
literature. Components of the figure and their interrela- tionships are described in the companion
Single-Case Reporting guide- line In BEhavioural interventions (SCRIBE) 2016 Statement article (Tate
et al., 2016). In brief, surveys of the literature (e.g., Perdices & Tate, 2009; Shadish & Sullivan, 2011) have
identified multiple designs using a single participant. The figure presents nine prototypical designs,
but not all of these use single-case methodology, as defined (i.e., containing multiple phases during
each of which the dependent variable is measured repeatedly; see Footnote 2). In particular, the three
designs below the solid horizontal line (B-phase training study, pre–post intervention eval- uations
alone, and case description) do not meet these criteria and they are not SCEDs.
1 Levels of evidence refer to the hierarchy of strength or credibility of evidence that different research designs yield. The
hierarchy is frequently used in medicine to critically evaluate the available evidence for different clinical questions (e.g., inter-
ventions, harms, diagnosis, prognosis). There is some variation among different classification systems (see, e.g., websites of the
American Academy of Neurology, www.aan.com; Oxford Centre for Evidence-Based Medicine, www.cebm.net).
2 Single-case methodology is defined as the intensive and prospective study of the individual in which (a) the intervention/s
is  manipulated in an experi- mentally controlled manner across a series of discrete phases, and (b) mea- surement of the
behavior targeted by the intervention is made repeatedly (and, ideally, frequently) throughout all phases. Professional guidelines
recommend that the experimental effect be demonstrated on at least three occasions by systematically manipulating the
independent variable (Horner et al., 2005; Kratochwill et al., 2010, 2013). This criterion helps control for the confound- ing
effect  of extraneous variables that may  adversely affect internal validity (e.g., history, maturation), and allows a functional
cause and effect relationship to be established between the independent and dependent variables.
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The SCRIBE 2016 applies to those designs above the solid horizontal line, which all use single-
case methodology, but differ fundamentally in terms of their structure. The four prototypical
designs above the dotted horizontal line comprise the withdrawal/reversal, multiple-baseline,
alternating/simultaneous-treatments, and changing-criterion designs. Re- porting requirements dif-
fer among the designs, and are described in the SCRIBE 2016 Item 5. The medical N-of-1 trial falls
within the with- drawal/reversal paradigm, and a separate reporting guideline is available for that
design (see Shamseer et al., 2015 and Vohra et al., 2015 for the CONSORT Extension for N-of-1 Trials
[CENT 2015]). Randomization of elements in all of the foregoing designs is feasible (see Kratochwill &
Levin, 2010), albeit not common practice, and is covered in the SCRIBE 2016 Item 8.
Each of the designs also varies in terms of methodological rigor and even experimental designs
above the dotted horizontal line may  not meet design standards, such as those of Horner et al. (2005)
and Kratochwill et al. (2013). The reason that the biphasic A-B design is separated from the other
designs above the dotted horizontal line is because of its poor control of threats to internal validity. It
is for this reason that the A-B design, although using single-case methodology, is regarded as quasiex-
perimental (Barlow, Nock, & Hersen, 2009). Scientific quality for both internal and external validity can
be measured with methodological quality rating scales designed for single- case methodologies, such
as those described in Maggin, Briesch, Chafouleas, Ferguson, & Clark (2014) and Tate et al. (2013b).
The behavioral sciences literature is highly variable with respect to the adequate conduct and
complete reporting of single-case research. The systematic review of Maggin, Chafouleas, Goddard,
and Johnson (2011) into SCEDs to evaluate token economy interventions for students with challenging
behaviors found evidence of incomplete reporting. Of 24 eligible studies, a significant proportion
failed to report on basic demographic features of the participants, such as age (42%) and sex (33%).
Moreover, 21% of the studies did not provide information on who implemented the intervention
and 42% failed to specify the method used to record the data. Didden, Korzilius, van Oorsouw, and
Sturmey (2006) conducted a meta-analysis of 80 single-case reports on challenging behavior in mild-
to-moderate intellectual disability, finding that only 27% reported on procedural fidelity. Tate, Perdices,
McDonald, Togher, & Rosenkoetter (2014) reported on a random sample of 35% of reports archived on
the PsycBITE database published between 1990 and 2010 in the neurological conditions of dementia,
stroke and traumatic brain injury that used a single participant (n = 253). Only 14% reported using an
assessor who was independent of the therapist, 54% reported on interrater reliability of the dependent
variable, and 62% provided a session-by-session data record in graphed or tabular format. Smith (2012)
systematically reviewed the psychology and education literature between 2000 and 2010 specifically
to identify SCEDs, with 409 reports meeting eligibility criteria. Twenty-two percent of studies did not
report baseline data and 52% did not report either statistical or visual analyses of the data. These data
from different populations suggest that problems with the conduct and/or reporting of fundamental
elements of single-case research in the behavioral sciences are common and highlight the need for a
reporting guideline.
Reporting guidelines in the CONSORT tradition (see www.equator-network.org) improve the clar-
ity and transparency of reporting of randomized controlled trials (RCT) published in journals that
endorse them. A systematic review based on evaluations of more than 16,000 RCTs found that 25 of
27 CONSORT-related items were more completely reported in journals that endorse CONSORT com-
pared to those that do not, with five items being statistically significant (p = .01; Turner et al., 2012).
It is expected that the development and implementation of similarly structured guidelines to cover
common research designs used in SCEDs will assist (a) researchers to report on the requisite items
that foster complete- ness, clarity, transparency and accuracy of reporting and (b) read- ers to know
exactly what was done and what was found. The present report, referred to as the SCRIBE 2016 Expla-
nation and Elaboration article, provides description of and rationale for 26 reporting items, along with
examples of adequate reporting from the published literature. A separate SCRIBE 2016 Statement (Tate
et al., 2016) describes the methodology underlying development of the SCRIBE 2016.
The genesis of the SCRIBE 2016 derives directly from the foundation work and development of the
CENT 2015 (Shamseer et al., 2015; Vohra et al., 2015). Frequently, the medical interventions being
evaluated in N-of-1 trials use pharmacological or nonphar- macological substances that are injected,
ingested, inhaled, or topically applied. The design for these types of interventions sometimes involves
run-in/wash-out periods, which are consequently highly relevant to adequate reporting of such trials
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and specific items are required for the purpose of reporting. By contrast, the SCRIBE 2016 is intended to
apply to the broader variety of experimental single-case interventions used in the behavioral sciences,
including, but not restricted to, health conditions. Behavioral interventions are often multicomponen-
tial and complex, and some strategies to minimize bias, such as blinding, are difficult to implement. For
these reasons, two sets of reporting guidelines were deemed necessary to cater to the different types
of interventions and single-case methodologies used in the respective fields. Similar reasoning drove
the development of an extension of the CONSORT Statement for nonpharmacological RCTs (Boutron
et al., 2008). The CENT 2015 guideline is intended for use in medical N-of-1 trials, whereas the SCRIBE
2016 guideline is intended for SCEDs in the behavioral sciences.
As with the Strengthening the Reporting of Observational Stud- ies in Epidemiology (STROBE)
Statement for observational studies (Vandenbroucke et al., 2007), the SCRIBE 2016 is intended to cover
multiple research designs (specifically, the four most common prototypical experimental designs:
withdrawal/reversal, multiple-baseline, alternating/simultaneous treatments, and changing- criterion
designs, along with their variants, as well as adaptive designs). Although we did not intend the SCRIBE
2016 to apply to non-SCEDs using a single participant (designs shown below the solid horizontal line in
Fig. 1), authors of such articles may  find it useful to follow the guidance of those SCRIBE 2016 items as
may  apply to their study. Authors may  also wish to consult the reporting guide for clinical CAse REports
(CARE; Gagnier et al., 2014), the CONSORT for Social and Psychological Interventions (CONSORT-SPI;
Montgomery et al., 2013), and the Template for Intervention Description and Replication (TIDieR)
guideline (Hoffmann et al., 2014).
We  prepared the SCRIBE 2016 within the CONSORT tradition of guideline development (Moher,
Schulz, Simera, & Altman, 2010b). Accordingly, the focus of this article concerns the reporting of studies,
rather than education about the design of single-case experiments. Moreover, in our use of examples
from the literature to illustrate adequate reporting of each of the SCRIBE 2016 items, we  adopt the
position of Boutron et al. (2008), wherein use of an example for a specific item is not intended to
imply that the study also provides adequate examples of other items, nor even that the study per
se is methodologically sound. Thus, although some of the examples may  not meet design standards,
nonetheless they meet reporting standards in that they clearly describe what was done. The suggested
locations in the article for the SCRIBE 2016 reporting items are not prescriptive and authors should
use their discretion about the most suitable loca- tion.
Methodology
The first phase to develop the SCRIBE 2016 consisted of two rounds of an online Delphi survey
completed by SCED authors and methodology experts, resulting in 44 items to be discussed at a con-
sensus conference. At the meeting, held in Sydney, Australia, in December 2011, participants reworked
the items, resulting in a final set of 26 items for the reporting guideline, which are described in this
Explanation and Elaboration article. The SCRIBE 2016 Statement (Tate et al., 2016) provides a detailed
description of the methodology of this process.
Results
This article provides examples of adequate reporting from the literature for each of the 26 items,
along with a rationale for inclusion of the item and, where available, evidence of bias resulting from
incomplete report- ing (the SCRIBE checklist of items appears in Table 1).
Section 1: Title and Abstract (Items 1 and 2)
Item 1—Title: Identify the research as a single-case experimen- tal design in the title.
Example.
Graded exposure in vivo in the treatment of pain-related fear: a replicated single-case experimental
design in four patients with chronic low back pain. (Vlaeyen, de Jong, Geilen, Heuts, & van Breukelen,
2001, p. 151)
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Table  1
The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Checklist.
Item number Topic Item description
TITLE and Abstract
1  Title Identify the research as a single-case experimental design in the title
2  Abstract Summarize the research question, population, design, methods including
intervention/s (independent variable/s) and target behavior/s and any other




Describe the scientific background to identify issue/s under analysis, current
scientific knowledge, and gaps in that knowledge base




5  Design Identify the design (e.g., withdrawal/reversal, multiple-baseline,
alternating-treatments, changing-criterion, some combination thereof, or
adaptive design) and describe the phases and phase sequence (whether
determined a priori or data-driven) and, if applicable, criteria for phase change
6  Procedural
changes
Describe any procedural changes that occurred during the course of the
investigation after the start of the study
7  Replication Describe any planned replication
8  Randomization State whether randomization was used, and if so, describe the randomization
method and the elements of
the study that were randomized










For each participant, describe the demographic characteristics and clinical (or
other) features relevant to the research question, such that anonymity is
ensured
CONTEXT
12  Setting Describe characteristics of the setting and location where the study was
conducted
APPROVALS
13 Ethics State whether ethics approval was obtained and indicate if and how informed
consent and/or assent were obtained
MEASURES and
MATERIALS
14 Measures Operationally define all target behaviors and outcome measures, describe
reliability and validity, state how they were selected, and how and when they
were measured
15  Equipment Clearly describe any equipment and/or materials (e.g., technological aids,
biofeedback, computer programs, intervention manuals or other material
resources) used to measure target behavior/s and other outcome/s or deliver
the interventions
INTERVENTIONS
16 Intervention Describe the intervention and control condition in each phase, including how
and when they were actually administered, with as much detail as possible to
facilitate attempts at replication
17  Procedural
fidelity
Describe how procedural fidelity was  evaluated in each phase
ANALYSIS




For each participant, report the sequence actually completed, including the
number of trials for each session for each case. For participant/s who did not
complete, state when they stopped and the reasons
20  Outcomes and
estimation
For each participant, report results, including raw data, for each target
behavior and other outcome/s
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Table 1 (Continued)
Item number Topic Item description
21 Adverse events State whether or not any adverse events occurred for any participant and the
phase in which they occurred
DISCUSSION
22 Interpretation Summarize findings and interpret the results in the context of current evidence
23  Limitations Discuss limitations, addressing sources of potential bias and imprecision
24  Applicability Discuss applicability and implications of the study findings
DOCUMENTATION
25  Protocol If available, state where a study protocol can be accessed
26  Funding Identify source/s of funding and other support; describe the role of funders
Explanation. Although journals may  place word limits on the title, it is important to include as much
information as possible in the title, such as the intervention, the target behavior and the population.
In particular, the title should explicitly mention that the study is a SCED because this differentiates
the study from a case description. The abstract is sometimes copyrighted by the journal, so the title
may  be the only searchable information. Identifying the study as a SCED in the title will ensure that
the article is appropriately indexed for bibliographic databases (such as PsycINFO or Medline). Note
that using “SCED” as a key word will not be sufficient for this purpose because author key words are
different from database key words and may  therefore not be searchable in electronic databases.
Item 2—Abstract: Summarize the research question, popula- tion, design, methods including inter-
vention/s (independent vari- able) and target behavior/s and any other outcome measures (dependent
variable), results, and conclusions.
Example.
This study tested the effectiveness of Imagery Rescripting (ImRs) for com- plicated war-related
PTSD [posttraumatic stress disorder] in refugees. Ten adult patients in long-term supportive care with
a primary diagnosis of war-related PTSD and Posttraumatic Symptom Scale (PSS) score >20 par- tic-
ipated. A concurrent multiple baseline design was  used with baseline varying from 6 to 10 weeks,
with weekly supportive sessions. After baseline, a 5-week exploration phase followed with weekly
sessions during which traumas were explored, without trauma-focused treatment. Then 10 weekly
ImRs sessions were given followed by 5-week follow-up without treatment. Participants were ran-
domly assigned to baseline length, and filled out the PSS and the BDI [Beck Depression Inventory] on
a weekly basis. Data were analyzed with mixed regression. Results revealed significant linear trends
during ImRs (reductions of PSS and BDI scores), but not during the other conditions. The scores dur-
ing follow-up were stable and significantly lower compared to baseline, with very high effect sizes
(Cohen’s d = 2.87 (PSS) and 1.29 [BDI]). One patient did clearly not respond positively, and revealed
that his actual problem was his sexual identity that he couldn’t accept. There were no dropouts. In
conclusion, results indicate that ImRs is a highly acceptable and effective treatment for this difficult
group of patients. (Arntz, Sofi, & van Breukelen, 2013)
Explanation. The abstract needs to provide an accurate, infor- mative and unambiguous overview
of the study. It is important that all relevant information is included because many readers may  not
have access to the full article, or may  choose to limit their reading of the study to the abstract. The
CONSORT guideline for abstracts for randomized trials (Hopewell et al., 2008) provides useful infor-
mation about how to write an abstract which, although written for RCTs, has applicability to SCEDs. A
structured abstract can be useful and make the abstract easy to follow. It is important that the abstract
clearly describes relevant features of the participant/s (including clinical details where appropriate),
defines the depen- dent and independent variables, along with the SCED design used to examine their
relationship. The target behaviors and any addi- tional outcome measures (e.g., for generalization)
used in the study should be specified, along with the way in which the target behavior is measured.
An accurate summation of the outcomes of the study needs to be clearly detailed, along with disclo-
sure of any harms or adverse events, and conclude with a brief, cautious appraisal of the significance
of the research.
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Section 2: Introduction (Items 3 and 4)
Item 3—Scientific background: Describe the scientific back- ground to identify issue/s under anal-
ysis, current scientific knowl- edge, and gaps in that knowledge base.
Example (abbreviated).
Verb production problems are an extremely common and pervasive aphasic deficit following stroke.
Past research into word retrieval and production has mostly focused on nouns. More recently there
has been increased interest in verb retrieval and verb processing disturbances [ref]. Unfortunately.
One potentially useful speech pathology treatment for word production deficits involves the use of
arm and hand gestures. What remains to be developed is empirical evidence to support or refute the
suggestion that gesture is a potent treatment for verb retrieval deficits. This paper presents evidence.
(Rose & Sussmilch, 2008, pp. 692–693)
Explanation. The introduction is normally a discursive text that overviews the relevant literature
and identifies the gaps in knowledge that the current study aims to address. Ideally the text is succinct
and targeted to the main issues that frame the context of the study. The introduction should commence
with what is known about the problem area and its interventions, what is yet to be understood, and
how this study can address this gap.
Item 4 —Aims: State the purpose/aims of the study, research question/s, and, if applicable, hypothe-
ses.
Example.
The purpose of the present study was to examine the effects of a written cueing treatment pro-
gramme  on verbal naming ability in two adults with aphasia. Treatment involved using a written
cueing hierarchy, which was modelled after CART [Copy and Recall Treatment] and included verbal
and writing components. (Wright, Marshall, Wilson, & Page, 2008, p. 524)
Explanation. The purpose and aims of the study need to be clearly described, normally at the
conclusion of the Introduction. These should take the form of research questions that define the inde-
pendent variable, the dependent variable, and report if a formal relationship was assessed. Statement
of aims and, if applicable, hypotheses, provide the reader with explicit directions regarding the way
in which the design, methods and results should be read, given that these should all follow from the
aims/research questions being asked.
Section 3: Method—Design (including both design structure, as well as broader aspects of
internal and external validity), Participant/s, Context, Approvals, Measures and Materials,
Interventions, Analysis (Items 5–18)
Item 5—Design: Identify the design (e.g., withdrawal/reversal, multiple-baseline, alternating-
treatments, changing-criterion, some combination thereof, or adaptive design) and describe the phases
and phase sequence (whether determined a priori or data- driven) and, if applicable, criteria for phase
change.
Example 1: Withdrawal/reversal design.
An A-B-A-B single-subject design evaluated a token economy for increasing exercise in children
with CF [cystic fibrosis]. Two advantages of this design are that it provides two  evaluations of the
treatment compared to baseline and it ends on a treatment phase, which is important from a clinical
standpoint. The exercise diary data were used to determine when study phase changes were made.
The specific criteria were the following: (a) there were three or more stable data points, (b) there was
a predictable pattern in the data, or (c) there was  no pattern, but the data points were predictably
random. (Bernard, Cohen, & Moffett, 2009, p. 354–357)
Example 2: Multiple-baseline design.
A randomized, concurrent, multiple-baseline single-case design was applied.13 Participants com-
pleted repeated measurements during a baseline phase (phase A), an intervention period (phase B,
12 weeks) and a postintervention period (phase A = ). Phase A acted as a control and was  therefore
compared with phases B and A=. (Hoogeboom et al., 2012, p. 2)
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Example 3: Alternating-treatments design.
The study used a multielement design with no baseline [ref] and a final “best treatment” phase
[ref] to compare the effects of three contingent consequent events (Treatment A, adapted toys and
devices; Treatment B, cause-and-effect commercial software; and Treatment C, instructor cre- ated
video programs) on the frequency of stimulus activations. Students received intervention in alternating
treatments followed by the best treatment phase, in which only the most effective intervention was
delivered. (Mechling, 2006, p. 98)
Example 4: Changing-criterion design.
[This study evaluated] a prompting and shaping intervention, in the form of a changing criterion
design. [to] assist this athlete in the technical development of his vault and corresponding height
cleared. A photo- electric beam. was set across the runway at a height of 2.30 m (5 cm above the
mean height obtained during baseline). Intervention at this height continued until the participant
displayed stability in his performance at a 90% level. Stability in performance referred to the successful
repetition of three or more 90% performances. Following successful completion, intervention was also
administered at the following heights: 2.35. 2.52 m.  (Scott, Scott, & Goldwater, 1997, pp. 573–574)
Explanation. In a broad sense, the design of a SCED encompasses all components of the method-
ology. For the purpose of this item, it specifically refers to the basic structure of phase sequencing
and phase onset used in the investigation. That is, the design defines how the independent vari-
able is manipulated, what the baseline conditions are, and when/how the independent variable is
introduced/changed. Manipu- lation of these parameters allows the investigator to systematically
control the independent variable in order to demonstrate the experimental effect. Moreover, using
multiple phase changes in the design provides opportu- nity for repeated demonstration of the exper-
imental effect on the same participant. This constitutes direct intrasubject replication (see Item 7 for
intersubject replication and systematic replication).
The design of SCEDs is crucial for determining the adequacy of control of threats to internal validity
and the experimental effect (Horner et al., 2005; Kratochwill et al., 2013). Design characteristics need
to be clearly and specifically reported, otherwise it is difficult for the reader to
determine if the study has sufficient experimental control to ade- quately establish a functional
cause-effect relationship between the de- pendent and independent variables and (b) evaluate the
reliability of the results. In a small random sample of 20 reports using a single participant archived on
the PsycBITE database, 45% of reports did not provide any information on the type of design used and
an additional 20% incorrectly described the design (Tate et al., 2013b).
Specific reporting requirements will vary among the experimental designs. A major strength of
SCEDs is their flexibility and adaptability. In addition to the “classic” designs described below, elements
of these designs can be creatively combined in a multitude of ways depending on the research/clinical
question being addressed and the intervention being considered (e.g., see e.g., see Hayes, Barlow, &
Nelson-Gray, 1999). A fundamental requirement in reporting SCEDs is that the basic structure of the
design is explicitly and accurately described. This consists of reporting the following eight invariant
features that apply to all designs:
Basic information required for all designs, including withdrawal/reversal (A-B-A-B) design.
i The type of design (e.g., withdrawal/reversal)
ii The number of phases (including baseline, experimental, maintenance and follow-up phases)
iii The duration (length) of each phase
iv The order in which the phases are sequenced (e.g., random- ized, counterbalanced, data-driven)
v The number of sessions in each phase
vi The number of trials within each session in a phase (i.e., occasions when the dependent variable
is being measured)
vii The duration of sessions
viii The time interval between sessions (see also Item 20)
Additional descriptive information needs to be provided for spe- cific design types.
Additional information required for multiple-baseline designs.
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i The number of different (i.e., multiple) baselines (also referred to in the literature as data series, tiers,
levels or legs) that the design contains. A graph alone is insufficient, because a graph represents the
results that were obtained, rather than the design as planned, which may  change in response to the
intervention (see Item 6).
ii Whether the baselines are across participants, behaviors or settings
iii The method for determining treatment onset (e.g., response guided, randomization), or, if necessary,
that there was no specific rationale or empirical basis
iv Sometimes multiple-baseline designs also incorporate either a follow-up phase after the initial inter-
vention phase or an “em- bedded” design (e.g., alternating-treatments). When such a vari- ant is
utilized, the complete sequence of phases should be clearly stated in the design description.
v Whether or not the onset, and subsequent continuance, of data collection in each of the baselines
occurred concurrently (i.e., at the same points in time) or nonconcurrently. If nonconcurrent, provide
a rationale for this choice.
Additional information required for alternating-treatments designs.
i Whether interventions were administered on the same day/session (e.g., Intervention 1 in the
morning, Intervention 2 in the afternoon) or different days/sessions
ii The way in which the order of the interventions was  deter- mined (e.g., randomized, counterbal-
anced, Latin square)
iii The detailed phase sequence (e.g., inclusion of a baseline preceding the intervention; a final “best
treatment” phase fol- lowing the intervention)
Additional information required for changing-criterion designs.
i All criteria or decision rules used to determine when a phase change occurs
ii Whether the criteria are set a priori or are response guided
Additional information required for adaptive designs. In these designs, the structure of the inves-
tigation (e.g., phase sequence/dura- tion, interventions, variations in intervention) is not fixed a priori,
but depends, on an ongoing basis, on characteristics of the data (or responses) from early (or preceding)
phases, Authors should also clearly describe the following:
i Features or characteristics of the data (operationally defined) that are used to regulate the study
design
ii Which specific aspects of the study design, at each and all steps in the study, are determined by
which specific features of the data
Item 6 —Procedural changes: Describe any procedural changes that occurred during the course of
the investigation after the start of the study.
Example.
BST [behavioral skills training] was implemented with each child individually in two 15- to 20-min
sessions. If the child did not obtain a score of 3 during an assessment after the initial BST sessions and
two booster sessions, an additional assessment session was  turned into a training session. For Jake,
who did not exhibit the correct behavior following BST or in situ training, an incentive phase was
added. (Miltenberger et al., 2004, pp. 514–516)
Explanation. There are occasions when, for a variety of reasons, the proposed implementation of a
study changes from the original plan. Changes may  occur to any component of the study, including (a)
methodological design; (b) setting in which the study takes place; (c) target behavior and any other
outcome measures, with respect to content, method or frequency of administration; (d) equipment
or materials to deliver the intervention; (e) use of practitioners and assessors; or (f) the intended
intervention. Changes involving participant attrition or early termination of phases are addressed in
Item 19.
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The researcher may  actively initiate changes that are a departure from protocol or they may  be
thrust upon the researcher as a result of external factors. With respect to changes in the intervention,
one of the reported strengths of single-case methodology is the flexibility of implementation of the
intervention (Connell & Thompson, 1986; Gravetter & Forzano, 2009). If adverse events occur or the
intervention is not working sufficiently, then it is acceptable for the researcher to make alterations
without necessarily compromising experimental control.
Authors need to report any changes or departure from the original plan or protocol, such as those
listed above, along with reasons. They should also provide a statement about their impact on the
interpreta- tion of the results. Places to describe procedural changes in the report will depend on the
type of change/s, but either the Method or Dis- cussion sections are appropriate.
Item 7—Replication: Describe any planned replication.
Example 1: Systematic replication.
We employed a multiple-baseline design to test the efficacy of a recently developed approach for
reducing school refusal behavior. To maxi- mize external validity, the intervention was tested using
a systematic replication strategy, whereby only the major conceptual elements of the intervention
were retained from previous applications. (Chorpita, Albano, Heimberg, & Barlow, 1996, p. 281)
Example 2: Direct intersubject replication.
A single-subject ABAC design with replication across three participants was employed. (Leon et al.,
2005, p. 96)
Explanation. Replication is a key feature of single-case method- ology and is important because
it has the capacity to inform whether and the extent to which an intervention is generalizable and
hence is important for external validity. In spite of its central significance, replication is not commonly
reported, with just over half of the studies (54%) in the neurorehabilitation survey of Tate et al. (2014)
describing replication. In addition, although it may  be evident that there is replication in a study, it is
not always explicitly stated.
Three types of replication are described in the literature (Barlow et al., 2009; Gast, 2010a; Horner
et al., 2005; Kratochwill et al., 2010, 2013; Sidman, 1960). Direct intrasubject replication refers to
replication of the experimental effect within the design and addresses issues of internal validity (see
Item 5). The other two types of replication are relevant to this item: (a) systematic replication (i.e.,
repeating the experiment with the same intervention but systematically changing characteristics of
the in- dividuals, setting, interventionists and/or behaviors) and (b) direct inter- subject replication
(i.e., repeating the same study but with additional individuals).
Using a series of replications, Horner et al. (2005) and Kratochwill et al. (2010, 2013) note that it
is possible to provide a strong basis for causal inference. They have proposed criteria for the purpose
of establishing evidence-based treatments: (a) a minimum of five methodologically strong research
reports, (b) conducted by at least three different research teams at three different geographical loca-
tions, and (c) with the combined number of cases being at least 20.
Authors should clearly and specifically state the number and type of replications in the Abstract
and the Method section. If the study is using systematic replication to build an evidence-base, authors
may  consider using the term systematic replication in the title. Authors need to clearly indicate whether
the replication refers to (a) the replication of a previously published study or (b) intersubject repli-
cation within the current study.
Item 8 —Randomization: State whether randomization was  used, and if so, describe the random-
ization method and the ele- ments of the study that were randomized.
Example 1: Randomized sequence.
Two treatments, one imitative and one cognitive-linguistic, were employed and treatment order
was determined randomly. (Leon et al., 2005, p. 96)
Example 2: Randomized sequence (with restricted randomization).
A single case randomised experimental design with 12 phases was  used. Each phase lasted for one
week. During six treatment phases, participants wore the equipment and received cues (contingency
elec- trical stimulation). During six no treatment phases, participants wore the equipment, but no cues
were received. The phases were administered in a random order but always starting with a treatment
phase, and no more than two consecutive phases were the same. (Wenman et al., 2003, p. 449)
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Example 3: Randomized onset.
The start of the treatment phase was determined randomly for each participant, given the restric-
tion that the baseline phase should last for at least 6 weeks (42 days) and at most 12 weeks (84 days).
This means that the treatment phase could start on any day between the 42nd and the 84th days,
resulting in a total of 43 possible assignments. (ter Kuile et al., 2009, p. 151)
Explanation. The concept of randomization in SCEDs differs from its application in between-groups
designs. In between-groups designs, randomization exclusively refers to allocation of participants to
intervention groups (i.e., experimental vs. control). By contrast, in SCEDs, it refers to (a) the random
sequencing of baseline and inter- vention phases, (b) the random determination of the commencement
time for each phase, and (c) the combined randomization of both phase order and phase starting point
(Kratochwill & Levin, 2010). If more than one participant is being studied in withdrawal/reversal
designs, individuals can also be randomly assigned to intervention conditions. In multiple-baseline
designs, random allocation of partic- ipants, behaviors or settings to each baseline of the design can
also be implemented. Ferron and Levin (2014) and Kratochwill and Levin (2010) provide descriptions
of these options.
The sequencing of baseline and intervention phases in SCEDs may  be randomized using either sim-
ple (unrestricted) or blocked (restricted) randomization strategies (hence, randomized order de-signs).
The commencement point in time of each phase may  also be randomized using simple randomization
(hence, randomized start point designs). Randomization of both phase order and phase start point
can also be combined in any given design (Kratochwill & Levin, 2010). Random allocation in SCEDs
provides control of potential confounders related to time (Edgington, 1996; Kratochwill & Levin, 2010;
Onghena & Edgington, 2005) which addresses at least two  potential sources of experimental bias in
SCEDs: history and maturation.
Researchers can also use randomization to assign specific stimulus items to different stimulus
sets (e.g., treated and nontreated stimuli), although this type of randomization does not control for
experimental bias related to history and maturation.
When randomization is used, authors should provide a reason for why it was used. They should
also report specific details of (a) the basic randomization strategy (i.e., simple or restricted) and (b)
those aspects of the design that were randomized (e.g., phase order, phase commencement, allocation
of participants to interventions, allocation of participants, behaviors or settings to baselines). Authors
need to describe any restrictions or modifications to the randomization pro- cess, which may  be
necessary for clinical or ethical reasons.
If randomization was not used, authors need provide a reason why  it was  not used. They also need to
report any decision criteria used to determine phase sequencing (e.g., counterbalancing), time points
for phase onset (e.g., data driven), allocation of participants to interventions (if applicable), and/or
allocation of participants, behaviors or settings to tiers. If decision criteria are based on participant-
related reasons (e.g., clinical considerations, severity of behavior, participant needs), these need to be
reported.
Item 9 —Blinding: State whether blinding/masking was  used, and if so, describe who was
blinded/masked.
Example 1: Blind assessor.
The PQS [Psychotherapy Process Q-Sort] raters were not involved in any other aspect of the
study procedures, and had no prior information regarding intended treatment approaches, design,
or hypotheses. The raters were blind to the session number, treatment, and phase. Ratings of study
tapes were made as part of PQS ratings of sessions from a larger sample [ref], and therefore were not
rated consecutively or in comparison to one another. (Satir et al., 2011, p. 406)
No suitable examples of blinding of participant or practitioner in the SCED behavioral sciences
literature were identified.
Explanation. Blinding (or masking) “refers to keeping trial participants, investigators (usually
healthcare providers), or assessors (those collecting outcome data) unaware of an assigned inter-
vention, so that they are not influenced by that knowledge” (Schulz & Grimes, 2002, p. 696). Lack of
blinding or inadequate blinding in RCTs can inflate estimates of intervention effects by up to 17%,
especially if trial outcomes involve subjective measures (Wood et al., 2008). It is not unreasonable
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to expect that this also applies to SCEDs. Blinding in SCEDs is reported very rarely, particularly for
participants and practitioners (Tate et al., 2013b).
Blinding is difficult to achieve in nonpharmacological trials involving surgery, psychological inter-
ventions or rehabilitation (Bang, Ni, & Davis, 2004; Boutron, Tubach, Giraudeau, & Ravaud, 2004).
Given that the majority of SCEDs involve nonpharmacological interven- tions, this is a pertinent
issue. Although difficult, blinding of persons providing the intervention in nonpharmacological tri-
als is not insurmountable (e.g., e.g., Edinger, Wohlgemuth, Radtke, Marsh, & Quillian, 2001). Boutron
et al. (2007) provide a selection of strategies that can be used for blinding participants. By contrast,
blinding/masking of assessors is usually feasible.
In reporting SCEDs, if blinding was not implemented, authors should state the reasons. When
blinding was implemented, authors should clearly report who was blinded, and how the blinding
was achieved. Going beyond basic reporting standards, authors may  wish to consider reporting on
procedures to assess the effectiveness of the blinding procedures and the outcome.
Item 10 —Selection criteria: State the inclusion and exclusion criteria, if applicable, and the method
of recruitment.
Example.
We advertised the project in community newsletters and notices sent to local hospitals and rehabil-
itation professionals who typically worked with individuals with brain injuries. In the advertisements,
we stated the following inclusion criteria: parents must have a documented brain injury, the children
should be under the age of 10, and they must be demonstrat- ing behavioral difficulties with the
injured parent. Through subsequent observation of the parent and child, we  determined whether the
child was demonstrating a serious level of oppositionality with the parent (e.g., noncompliance to
more than approximately 50% of parent-delivered requests). (Ducharme, Davidson, & Rushford, 2002,
pp. 586–587)
Explanation. Readers of SCEDs need to know as much as pos- sible about the participant(s), within
the boundaries of anonymity, because, until generality has been demonstrated, results are only rep-
resentative of the conditions under which the investigation was conducted and for the individual/s
who participated.
In situations where participants were actively recruited into the study, inclusion and exclusion
criteria should be provided. This in- formation will assist with the identification of factors that may
influ- ence a participant’s response to the intervention. It will also give an indication of the extent
of the replicability and generalizability of research findings (see also Item 11). The description of the
selection process should provide detail regarding who  was recruited, and also the way in which the
participants were recruited (such as newspaper advertisements, online recruitment targeting specific
users, snowball- ing methods via other study participants or relevant professionals, distribution of
brochures and leaflets).
Information should be provided about the way in which selection criteria were applied (e.g., by use
of diagnostic instruments including questionnaires and interviews). Details of methods, instruments
ad- ministered, and classification or assessment criteria need to be clearly defined. Readers need to be
able to unambiguously identify how participant selection was accomplished for successful replication
of research (Horner et al., 2005).
Method of recruitment may  not be applicable in SCEDs in those situations where an individual
presents with an issue that needs to be addressed. Such issues may  be clinical (e.g., increasing a child’s
food intake) or nonclinical (e.g., improving an athlete’s perfor- mance). In these circumstances, authors
should instead state the reasons that the individual presented to the service and the reason for the
intervention.
Item 11—Participant characteristics: For each participant, de- scribe the demographic characteris-
tics and clinical (or other) features relevant to the research question, such that anonymity is ensured.
Example.
Three individuals with aphasia participated in the study. All had acquired aphasia secondary to
a left hemisphere stroke. See Table 1 for participant’s demographic data. Based on test performance
and clinical judgment, all participants had nonfluent aphasia with good audi-tory comprehension. All
participants exhibited significant word retrieval difficulties. Participants’ performances on the BNT
[Boston Naming Test] were reviewed. P1’s word retrieval errors consisted of a mix  of semantic (e.g.,
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boat for canoe) and phonemic errors (e.g., fesmask for mask). (Rider, Wright, Marshall, & Page, 2008,
pp. 162–163)
Explanation. Inclusion of standard baseline participant characteristics, including demographic
information and functional status, ensures that the reader understands the presentation of the partic-
ipants and will be able to interpret the findings (Higginbotham & Bedrosian, 1995). It is also important
for generalization (Barlow et al., 2009) and facilitates meta-analysis of multiple studies (Robey, Shultz,
Crawford, & Sinner, 1999). In spite of their relevance and importance, the systematic review of Mag-
gin, et al. (2011) found that participant characteristics were incompletely reported, even for very
basic demographic features such as sex (not reported in 33% of reports) and age (not reported in 42%
of reports).
The description of the participants of a study should include basic demographic information such
as age, sex, ethnicity, socioeconomic status, geographic location, as well as diagnoses where indicated,
and functional or developmental abilities (Wolery & Ezell, 1993). Any diagnosis used should include
instrumentation and scores. Lane, Wolery, Reichow, and Rogers (2007)also recommend that baseline
or environmental factors which serve to influence or maintain the participant’s behavior during the
initial baseline should be evaluated and reported. These features will go beyond simple description of
sociodemographic, medical and functional status variables.
Authors need to ensure that information provided does not lead to identification of the participant.
This is a particular risk in the treat- ment of rare conditions. It is also important to protect an individual’s
privacy if the study involves stigmatized conditions.
The participant in a SCED typically, but not always, represents an individual person. The participant,
however, can also be a group whose performance generates a single score per measurement period
(such as the rate of a particular behavior performed by all students within a classroom during a set
period of time). In that situation they are generally referred to as a “case” or “unit.” It is important that
the authors opera- tionally define what constitutes the group and provide criteria for its selection (see
Item 10). Authors need to specify the baseline character- istics (to the same level of detail) for each
participant (Wolery & Ezell, 1993) to allow the reader to ascertain the extent to which the results are
generalizable (see also Item 24).
Item 12—Setting: Describe characteristics of the setting and location where the study was con-
ducted.
Example.
The children and teacher comprised the full membership of a third grade general education class-
room in a rural postindustrial Northeast elemen- tary school. All observations were conducted in their
homeroom class during the SSR [sustained silent reading] period. During SSR, students sat at their
desks, which were arranged in two rows of desks facing toward the teacher in the front of the room.
(Methe & Hintze, 2003, p. 618)
Explanation. It is critical to report the setting and location of the study because these factors have
implications for the generalizability and applicability of the findings (see Item 24). The context of the
intervention will vary according to whether it is provided in primary, secondary or tertiary health
care, classroom/educational facility or community settings. The location of the study will also vary
according to whether the intervention is offered in urban, rural or remote locations, and this will have
an impact on the service delivery model. The setting is of particular interest for the reporting of SCEDs
for two reasons. First, it may  be an inherent a priori feature of the design to introduce the independent
variable across a range of settings in a con-trolled manner. Multiple-baseline designs across settings
are a case in point. Second, the detailed description of the relevant location and setting is central to the
replicability of the study (see also Item 7). An indepen- dent researcher may  be interested in varying
the location of the study as one step toward systematic replication. In this scenario, a sufficiently
detailed description of the setting is requisite information.
Authors need to provide detailed information on the location of the study, including the number
and type of settings, as well the practitioners or providers involved. There should be sufficient detail
regarding the location and setting of an intervention to enable others to evaluate how different this
is from their own situation.
Item 13—Ethics: State whether ethics approval was  obtained and indicate if and how informed
consent and/or assent were obtained.
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Example.
Approval for this research study was obtained from the human subjects research Internal Review
Board at participating institutions. If a woman was interested, she was  given a pamphlet with informa-
tion about the intervention and proposed research project before leaving the hospital, or at a follow-up
appointment. Women  then contacted the primary inves- tigator (SMB) for more information and/or
to schedule an initial assess- ment appointment. An informed consent form was  read, discussed and
signed before beginning the initial assessment and a copy of this consent form was given to the
participant for their records. (Bennett, Ehrenreich-May, Litz, Boisseau, & Barlow, 2012, p. 166)
Explanation. It is virtually a universal requirement that research involving human participants
requires review by and approval from an Institutional Ethics Committee. If the SCED was implemented
as part of clinical care, ethics approval might not be required, as is the case in N-of-1 trials (Punja,
Eslick, Duan, Vohra, & the DEcIDE Methods Center N-of-1 Guidance Panel, 2014). Reporting whether
ethics ap- proval has been obtained is not, however, a feature of all research reporting guidelines.
For example, the CONSORT Statement (Moher et al., 2010a) does not include this as a checklist item.
Following the CENT 2015 guidelines (Shamseer et al., 2015; Vohra et al., 2015), the SCRIBE 2016 also
includes the reporting of ethical approval as a checklist item for reporting SCEDs.
Written informed consent should always be secured (Mechling & Gast, 2010). There may  be
instances when the participant cannot provide informed consent (e.g., if the participant is a minor
or otherwise legally unable to provide informed consent). In this situation, their assent to partici-
pate should be sought, and consent also obtained from legal guardians or parents. It is not sufficient
to merely state informed consent/assent was obtained. Rather, the process by which consent/assent
occurred needs to be described so that it is clear who provided informed consent/assent. This is par-
ticularly important with vulnerable populations or where lim- ited disclosure is necessary (National
Health and Medical Research Council, 2009).
Item 14 —Measures: Operationally define all target behav- iors and outcome measures, describe
reliability and validity, state how they were selected, and how and when they were measured.
Example 1: Operational definition of the target behaviors and how they were measured.
Topographies of targeted behaviors for Bob included self-injury. Self-injury consisted of face slap-
ping, defined as a forceful contact between an open palm and cheek. Bob also displayed spitting,
defined as spittle landing within 1 foot of another person.
The primary dependent variable was the percent of intervals in which maladaptive behaviors were
observed during each 10-min session. Data were collected using paper and pencil during consecutive
10-s intervals cued by an audio tape throughout the entire session, resulting in a total of 60 consecutive
intervals. Partial interval recording was used: during each interval observers recorded whether or not
any of the target maladaptive behaviors had been observed for any portion of the interval.
Observers underwent training in behavioral observation. and dem- onstrated mastery prior to
participating in the study. (Treadwell & Page, 1996, pp. 65–66)
Example 2: Reliability of dependent variables when using non- standardized measures.
Three different categories of interobserver agreement were calculated, as follows. Parent-therapist
agreement: This category involved agreement between compliance data coded by the parent and those
coded live by the research therapist. In this category, interobserver agreement was  obtained on 39% of
sessions conducted by parents, randomly selected from each of the phases across all children. Overall
agreement averaged 92% for baseline (range 82%–100%) and 98% for treatment, generalization, and
follow-up sessions (range 94%–100%). (Ducharme et al., 2002, p. 588)
Explanation. A single item in the SCRIBE 2016 covers all as- pects of the dependent variable/s: the
what, how, and when of mea- suring the effect of the intervention. As with other research designs, the
measurement process in SCEDs also needs to be valid and reliable. Validity is enhanced by selecting
dependent variables that are (a) relevant to the behavior in question and that best match the interven-
tion, as well as (b) accurate in their measurement, which is facilitated when the behavior that is tar-
geted for intervention is operationally defined. Reliability is enhanced when the behavior is measured
in a manner that yields consistent results.
What is measured? SCEDs commonly use a variety of dependent variables that play specific roles
in the experiment. The primary outcome variable in SCED methodology is referred to as the target
behavior. Target behaviors have three defining features in order to enhance quality of the study and
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minimize bias: they are specific, observable and repli- cable (Barlow et al., 2009). Other dependent
variables frequently used in SCEDs may  be considered akin to secondary outcome variables: Gener-
alization measures are increasingly recognized for their important role in contributing to the external
validity of the study (see also Item 24). In addition, SCEDs have a strong tradition in promoting exper-
iments that address socially relevant behaviors and interventions. Additional mea- sures are often
incorporated into a SCED to specifically measure social and ecological validity.
Authors need to provide operational definitions of the target be- havior, which should be objective,
clear and complete (Kazdin, 2011), in order to convey what does and does not constitute an instance
of the dependent variable. In studies where there is more than one target behavior, the report should
clearly identify and describe each of the target behaviors in detail. Other dependent variables used in
the study (e.g., generalization measures, social validity measures) should also be described with equal
clarity and precision.
How is it measured? The “how” of measurement covers measure- ment procedures, including who
selected and measured the target behaviors and other outcome variables, along with their training in
the assessment procedures. Authors also need to provide information on the way  in which the depen-
dent variables were measured, justification for the selection of those measures, and detail regarding
what consti- tutes a correct or incorrect response.
Because the target behaviors are highly specific to the presenting case in SCEDs, formal psychome-
tric evaluation of the measures will generally not have been established. It is therefore recommended
practice that evaluation of interobserver agreement on the target behavior is conducted and reported.
When standardized instruments are used, it is essential that psychometric details regarding relia-
bility, validity and responsiveness of the instruments are reported. Any equipment used to measure
the dependent variable/s should also have established measurement properties, which, if available,
should be provided in the report.
When is it measured? A distinctive feature of SCEDs, in contrast to group methodology, is that
the target behavior (primary outcome variable) is measured repeatedly and frequently throughout
all phases, including the baseline and intervention phases. Smith (2012, p. 519) observes that “the
baseline measurement represents one of the most crucial design elements of the SCED.” In spite of
this, baseline data were not available for 22% of SCEDs in Smith’s systematic review. Moreover, in
other phases of the study, the number of data points could not be readily identified.
Target behavior/s need to be selected so that they are suitable for repeated and frequent measure-
ment. Previously, the recommended minimum number of data points per phase was  three (Barlow &
Hersen, 1984; Beeson & Robey, 2006), but more recently professional guidelines recommend a mini-
mum of five data points per phase (Horner et al., 2005; Kratochwill et al., 2010, 2013). There should be
a clear description of the number of sessions in which the target behavior is measured in each phase, as
well as the number of times it is measured in each session (i.e., number of trials per session). Frequency
of measurement of other out- come variables depends on their role. Recommended practice is that
generalization measures are probed continuously throughout all phases (Schlosser & Braun, 1994). By
contrast, evaluation of social validity can only logically occur after the intervention has taken place.
As with target behaviors, authors should clearly state the frequency and regularity of measurement
of all other outcome measures, including phases during which such measures were taken.
Item 15—Equipment: Clearly describe any equipment and/or materials (e.g., technological aids,
biofeedback, computer pro- grams, intervention manuals or other material resources) used to measure
target behavior/s and other outcome/s or deliver the interventions.
Example 1: Software.
Training in use of email interface: “Participants 1–4 used a mouse connected via USB port to acti-
vate the e-mail program. Participant 5 used a trackball instead of a mouse to accommodate his motor
impairment. The instructor used a number pad. to control presentation. The program was run on. a
laptop. An altered interface was also developed to assess generalization to a slightly differ- ent plat-
form. It included additional buttons. as well as rearrangement of existing buttons to novel positions.”
(Ehlhardt, Sohlberg, Glang & Albin, 2005, p. 571; p. 576)
Example 2: Materials.
Photo Cue Cards [ref] were used as instructional stimuli. Four target photographs and four control
photographs were selected for each child. Target stimuli are presented by child and instructional
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condition in Table 2. A stopwatch was used to time the length of experimental sessions. (Holcombe,
Wolery, & Snyder, 1994, p. 53)
Explanation. Target behaviors may  be measured using behav- ioral observations and standard-
ized scales (see Item 14) or, alterna- tively, equipment. Similarly, many interventions used in the
behav- ioral sciences are accompanied by materials and equipment. Complete and accurate reporting
of equipment and materials is central to the issues of replicability (see Item 7) and generalizability (see
Item 24). A detailed description of the independent variable (i.e., the intervention) will include not
only a description of the elements of the intervention (see Item 16), but also any specific equipment
used, along with the way in which the equipment operates. Such equipment will include training
manuals, computer programs, bio-feedback techniques or any other materials required to implement
the intervention.
When equipment is used to measure the dependent variable, the way  in which it operates needs to
be described, as well as its calibra- tion. In addition, its measurement properties, if available, should
be reported (see Item 14).
Item 16 —Intervention: Describe the intervention and control condition in each phase, including
how and when they were actually administered, with as much detail as possible to facilitate attempts
at replication.
Example.
Check-in sessions were scheduled once a week during baseline to collect paperwork, monitor
participant functioning, and to serve as an active waitlist control condition. Following the baseline
period, women entered the inter- vention phase, which consisted of eight weekly sessions lasting
approxi- mately 60 min. The therapist was the lead investigator of this study (SMB) who was a senior
graduate student at the time of data collection. Women  were told they could opt to include their
partners in treatment sessions if they wished. (Bennett et al., 2012, p. 166)
This description is accompanied by a detailed table (p. 165) de- scribing the session, primary goal
of each session, and brief description of session content and homework.
Explanation. Evidence of inadequate description of the intervention abounds in the broader health-
intervention research literature using group methodology (e.g., Boutron et al., 2008; Dijkers et al.,
2002; Glasziou, Meats, Heneghan, & Shepperd, 2008). The importance of describing the indepen-
dent variable itself in sufficient detail to allow replication has been emphasized in the general SCED
literature.
The independent variable needs to be operationally defined, similar to the descriptions of the target
behavior/s and the outcome measures (see Item 14). In situations where more than one intervention
is used (e.g., A-B-A-C-A-D, or alternating-treatments design) each intervention should be described. In
addition to ancillary aspects of the intervention (i.e., materials, manuals, stimulus items, equipment,
software programs or applications; see Item 15), the nature of the intervention per se needs to be
clearly specified. This description includes information on who  delivered the intervention and in which
mode, whether it be individual, group, distance, carer- or educator-focused, or whether telehealth or
other technologies were used. It is critical to report the exact number, duration and frequency of the
intervention sessions (Baker, 2012; Warren, Fey, & Yoder, 2007). Specifically, intervention intensity
or dosage should be described in terms of the following: (a) dose form (i.e., the typical task or activity
being used), (b) the dose (i.e., the number of times an active ingredient or teaching episode occurs
per session), (c) the dose frequency (i.e., the number of intervention sessions per unit of time), (d)
the total intervention duration (i.e., the total period of time in which an intervention is provided),
and (e) the cumulative intervention intensity (i.e., the product of dose by dose frequency by total
intervention duration; Warren et al., 2007). SCEDs typically compare the effect of an independent
variable with either a control condition or another independent variable (i.e., another intervention).
The control condition, often called the baseline condition in SCEDs, represents a period of time when
the participant’s target behavior is recorded repeatedly before the intervention is introduced. The
same degree of specificity that is used to describe the experimental intervention should also be used
for the control condition.
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Item 17—Procedural fidelity: Describe how procedural fidelity was  evaluated in each phase.
Example.
Adherence to treatment procedures was accomplished by use of a manual that described the steps
of the programme. In addition, an independent, trained observer watched videotapes of one training
session from each step of the training programme (25% of sessions), and tallied the opportunities for
the experimenter behaviours and the number of times the experimenter used the expected behaviour
(e.g., prompts, models, reinforcement). Adherence to the protocol was  calculated using the formula
(EA × 100)/ET, where EA = the experimenter behaviours. Procedural reliability was 95% to 100% for
each step. (Hickey, Bourgeois, & Olswang, 2004, p. 630)
Explanation. Wolery (1994) describes the collection of proce- dural fidelity data as having three
main functions: (a) to monitor the occurrence of relevant variables, (b) to provide documentation
that the experimental conditions occurred as planned, and (c) to provide information to practitioners
about the use of the interventions. In spite of the seriousness of unreliable implementation of the
experimental conditions, fidelity checks in SCEDs in the behavioral sciences are infrequent (27% in
the series of Didden et al., 2006). This result is comparable to the data on reporting quantitative
measurement of the independent variable in three reviews of the contents of Journal of Applied Behavior
Analysis (Hagermoser Sanetti & Kratochwill, 2007).
In recognition of the critical importance of the fidelity of the imple-
mentation of study protocols, an item addressing adherence to the pro- tocol was  introduced for
the CONSORT Extension to Nonpharmacologi- cal Treatments (Boutron et al., 2008). Application of a
prepared checklist or steps of a protocol is the best way to document procedural fidelity (see Borrelli
et al., 2005; Dane & Schneider, 1998; Gast, 2010b, pp. 99–101). Steps taken to evaluate procedural
fidelity should be reported by authors, including how it was measured and the results of its assessment.
If procedural fidelity is evaluated during the course of the study, and found to be suboptimal, authors
may  consider going beyond basic reporting standards to describe whether and what steps were taken
to improve procedural fidelity (Hagermoser Sanetti & Kratochwill, 2014).
Item 18 —Analysis: Describe and justify all methods used to analyze data.
Example 1: Use of visual analysis.
The split-middle technique [ref] was employed to detect changes in the number of successful shots
within phases and resultant trend lines (Barlow & Hersen, 1984). White proposed that level, slope,
and mean score of the celeration line (or trend) line be assessed as three descriptive analyses for
conclusions. Given that a point on the celeration line does not actually explain the performance level,
for brevity we have chosen to concentrate on the slope of the celeration line. (Mesagno, Marchant, &
Morris, 2009, p. 136)
Example 2: Use of statistical analysis.
As serial dependence. can bias the visual inspection,17 we  checked our data in each phase for
serial dependence using the lag-1 method.12 If data were found to be significantly correlated, we
transformed the data using a moving average transformation, in which the preceding and succeeding
measurements were taken into account.12,16 In addi- tion, randomisation tests for multiple-baseline
single-case designs were carried out. We  expected phases B and A9 to be superior to phase A in terms
of our health outcome assessment. Therefore, we  tested the null hypothesis that there would be no
differential effect for any of the measurement times using a randomisation test of the differences in the
means between the preintervention phase and the intervention or postintervention phase.17 A p value
of <0.05 was considered statisti- cally significant. For the premeasurements and postmeasurements,
we considered change scores of 20% on validated questionnaires as clin- ically relevant.32 We  used
Stata/IC 10.1 for Windows for the descrip- tive and visual analysis of the data and R version 2.14.1 for
the randomisation tests.31 (Hoogeboom et al., 2012)
Explanation. Both visual and statistical techniques can be used to analyze SCED data (see
Appendix). They are considered complementary rather than mutually exclusive (Maggin & Odom,
2014; Parker & Brossart, 2003; White, Rusch, Kazdin, & Hartmann, 1989) and should, arguably, be
used in combination (Davis et al., 2013; Smith, 2012).
Visual analysis relies upon visual inspection of the graphed data to draw conclusions regarding
the reliability and consistency of intervention effects (Lane & Gast, 2014). In the past, experts have
argued that visual analysis is the most sensitive and appropriate way  to detect intervention effects
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in SCEDs (e.g., Parsonson & Baer, 1986). It has been the traditionally preferred and most frequently
used approach (Busk & Marascuilo, 1992), but has significant limitations (for discussion, see Lane &
Gast, 2014; Smith, 2012). Authorities have proposed guidelines for systematiz- ing visual analysis (e.g.,
Kratochwill et al., 2010; Lane & Gast, 2014), but there is not yet complete agreement about decision-
making criteria to guide the process.
Statistical analyses have advantages in that they (a) use an explicit set of operational rules and
replicable methods, (b) provide a direct test of the null hypothesis, (c) utilize precisely defined criteria
for significance, (d) are useful when there is instability in the baseline or treatment effects are not
well understood, and (e) can help to control for extraneous factors (e.g., Kazdin, 1982a, 1982b). There
is no “universal gold-standard,” however, and authors should choose the analytic method for SCEDs
that is guided by a number of considerations: (a) design requirements and data assumptions, (b) the
research question being posed, (c) features of the data being analyzed, and (d) the interpretability, ease
of computation and proven validity of the technique for analysis of SCED data. For detailed discussion
of these issues, see Manolov, Gast, Perdices, and Evans (2014) and Shadish (2014). If statistical analyses
are used, authors need to report whether underlying assumptions and other requirements pertinent
to the technique were evaluated for the data set being analyzed. This informa- tion will allow the
reader to determine the suitability of the analytic methods used.
It is critically important that authors fully and clearly describe the method/s of analysis used,
regardless of whether they select visual, statistical or both techniques. Authors should state if the
method/s of analysis was prespecified before commencement of data collection, and those changes
(if any) that were subsequently made as a consequence of limiting/problematic features of the data.
The rationale for selecting the analytic technique in terms of its appropriateness to the study design
and the research question should be clearly stated, and the source reference describing the technique
should be cited. In the case of visual analysis, it is important to clearly report the features of the data
that were selected for analysis (along with reasons) and whether a systematic protocol was  used and,
if so, which one.
Section 4: Results—Sequence Completed, Outcomes and Estimation, Adverse Events (Items
19–21)
Item 19 —Sequence completed: For each participant, report the sequence actually completed,
including the number of trials for each session for each case. For participant/s who did not complete,
state when they stopped and the reasons.
Example: Deviation from protocol: Interruption of treatment. Ms.  O had 24 sessions of psy-
chotherapy over a one hundred and 47 day period, which included two periods of treatment
interruption; once in the middle of the BCT [Behavior Change Treatment] phase, and once at the
end of the BCT phase. Ms.  O was randomly assigned to receive AFT [Alliance Focused Treatment] for
the first 4-week therapy phase, BCT for the second 4-week therapy phase, and AFT for the last 4-week
therapy phase. The two treatment interruptions coincided with the Thanksgiving and Christmas hol-
idays, and occurred during BCT only. (Satir et al., 2011, p. 406)
Explanation. A major benefit of SCEDs lies in their flexibility. As described in Item 6, it is possible
during the conduct of the investigation to change and fine-tune procedures and interventions that do
not appear to be working. Any such deviation from the original plan of the study, however, needs to be
clearly reported (see also Item 25). The present item pertains specifically to the report of procedural
variations that reflect changes in any of phase sequence, phase order, and/or number of sessions
actually com- pleted by each participant.
Changes to phase sequence may  occur in response to clinical or ethical concerns, such as
subsequently deciding to commence the investigation with a treatment phase rather than the pre-
determined randomized sequence. For similar reasons, a phase might be pre- maturely terminated,
interrupted, extended, or substituted for rea- sons of lack of efficacy, harms, periods of absence, and so
forth. Post hoc changes to the randomization schedule or the intended duration or structure of phases
can significantly weaken the inter- nal validity of the study and therefore need to be reported.
Missing data due to attrition may  bias the results, especially if this reflects intentional or systematic
noncompliance (Smith, 2012). Moreover, if participants do not complete all phases as planned, there
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may  also be insufficient phase repetitions to dem- onstrate adequate experimental control. Attrition of
participants within units (such as classrooms) over time may  confound inter- vention effects especially
if attrition is nonrandom and associated with the intervention itself.
In order to minimize such bias, Horner et al. (2005) argue that, regardless of attrition or miss-
ing data, results of any participant for whom there is data for both a baseline and an intervention
phase should be reported. If techniques for dealing with missing data are used (e.g., retrospective data
completion, such as completing dia- ries), this also needs to be reported, given that such techniques
can introduce significant bias in the data due to incorrect recollection/recall (Bolger, Davis, & Rafaeli,
2003). Accordingly, any changes to the sequencing of phases or missing data should be reported, along
with their reasons so that the reader can evaluate the integrity of the results and their interpretation.
Item 20 —Outcomes and estimation: For each participant, re- port results, including raw data, for
each target behavior and other outcome/s.
Example 1: Provide raw data (Fig. 2). Example 2: Statistical analysis.
The three measures of treatment gains are shown in Table 2. Four patients. demonstrated sig-
nificant treatment gains as determined by all three measures (C statistic, effect size, modified CDC
[conservative dual criteria]). One patient. did not demonstrate significant gains on any measure. The
patients who improved made variable gains in other areas as indicated by a significant increase in
their WAB  [Western Aphasia Battery] AQs [Aphasia Quotient] (mean increase = 5.58, SD = 2.32, t = 4.81,
df = 3, p < .05). (Crosson et al., 2009)
Explanation. Traditionally, SCED results are reported in graphical form which is, arguably, the
clearest and most unambig- uous way of depicting the major features of the raw data. At minimum,
SCED data for each session should be reported in graphic form. This does not preclude the additional
reporting of raw data for each session (or for each trial within a session) for each phase of the study in
a tabulated format. Although tabular presentation is acceptable (and even desirable for verification in
meta-analysis), relevant features (e.g., consistency across similar phases) may  not be directly obvious
in this format. Alternatively, authors may  provide information about where the raw numerical data set
can be accessed. Raw data should be reported in the results section for each measurement point/session
in each phase of the study for each participant, setting and target behavior/s. Even though aggregation
of data (e.g., averaging results over several sessions), may  provide a clearer view of the apparent
intervention effect, it may  also mask or misrepresent various important features. Such features may
include (a) stability of the initial baseline phase, variability and trends within a phase, (c) degree of
consistency between similar phases (e.g., intervention phases), (d) the degree of overlap between
baseline and intervention phases, (e) magnitude of effect latency following intervention phase onset.
Readers need to be able to critically evaluate all these aspects of the data. They also need to be able to
draw their own conclusions about how adequately the investigators have taken any anomalies into
account when appraising the clinical value of the intervention (Barlow et al., 2009).
The metric used on the horizontal axis of graphed data should be in units of real time (i.e., days,
weeks, etc.) rather than session number. This information allows the reader to more clearly inter-
pret and critically evaluate the results of the study. Providing an exact chronology of the time interval
between sessions allows the reader to accurately evaluate patterns of consistency between sim- ilar
phases and effect latency following intervention onset. Carr (2005) argues that using a real-time metric
on the horizontal axis is particularly relevant in multiple-baseline designs. The reason is so that the
reader can determine the order in which sessions across participants, settings or behaviors were
conducted relative to each other. More importantly, it also allows the reader to see how many sessions
occurred in the initial A-phase of the second baseline (or third, fourth, etc.) of the design after the
intervention was intro- duced in the first baseline.
Results of any statistical analyses for the target behavior/s and other relevant outcome variables
also need to be reported. This report should be done for each participant and setting in the study.
Irrespective of the analysis used, authors need to clearly state which phases and features of the data
were compared. Any changes or deviations in a preplanned analysis strategy should also be reported,
as well as the reasons that it was necessary to make such changes. For statistical analyses, the value















Fig. 2. “Jason’s frequency of challenging behaviors, across settings.” Reprinted from “Structured Flexibil- ity: The Use of Context-Sensitive Self-Regulatory Scripts to Support Young Persons
With  Acquired Brain Injury and Behavioral Difficulties,” by T. J. Feeney, 2010, Journal of Head Trauma Rehabilitation, 25,  p. 419. Copyright 2015 by Wolters Kluwer Health. Reprinted with
permission.
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Item 21—Adverse events: State whether or not any adverse events occurred for any participant
and the phase in which they occurred. The current reporting of adverse events is rare in SCEDs where
behavioral interventions have been applied. Only a single example (Hoogeboom et al., 2012) was
identified where authors mentioned that adverse events were monitored, but no information was
provided on the way in which adverse effects were measured, nor were results provided.
Explanation. The reporting of adverse events or harms is rare in SCEDs of behavioral interventions.
Their report is a more common feature in medical interventions in randomized and non-randomized
trials and observational studies (Golder, Loke, & Bland, 2011), even though it is often inadequate
(Papanikolaou, Christidi, & Ioannidis, 2006; Vandenbroucke, 2006). This problem is despite the report-
ing of harms being a specific checklist item in the CONSORT 2010 Statement (Schulz, Altman, & Moher,
2010). Although there are no clear definitions of harms,  the CONSORT Extension for Better Reporting
of Harms in RCTs (Ioannidis et al., 2004) has recommended harms as the preferred term to describe
an adverse event (as opposed to describing the “safety” of a treat- ment). Particular recommendations
include that (a) authors make specific mention of harm in the title or abstract, as well as the intro-
duction where harms are a primary outcome measure; and (b) there is specification of the harms in
reporting of results, with special attention paid to discontinuations and withdrawals due to adverse
events. The guideline also recommends that authors should present the absolute risk of each adverse
event (specifying type, grade, and seriousness per arm of the trial), (b) describe any subgroup analysis
and exploratory analysis for harms, and (c) provide a balanced discussion of benefits and harms with
emphasis on study limitations, generalizability and other sources of infor- mation on harms (Ioannidis
et al., 2004). The guide can be adapted to accommodate SCED methodology.
The SCRIBE 2016 recommends that authors make full and explicit disclosure of any harms or adverse
events that occurred to any participant during the course of the SCED trial, including the absence of
these events. Loke, Price, Herxheimer, & the Cochrane Adverse Effects Methods Group (2007) suggest
a framework to enable a systematic, manageable and clinically useful way to define adverse effects. It
includes a predefined classification of adverse effects as diagnosed by the clinician, by test results, or
by participant- reported symptoms (e.g., pain).
Section 5: Discussion—Interpretation, Limitations, Applica- bility (Items 22–24)
Item 22—Interpretation: Summarize findings and interpret the results in the context of current
evidence.
Example.
Results showed that the repeated reading program combining several research-based components.
improved fluency on second-grade trans- fer passages for the three participants lending support to
the existing literature on repeated reading [ref]. With research on repeated reading spanning decades
and numerous studies demonstrating successful out- comes. this practice holds great promise as a
strategy for improving reading fluency. However, as suggested by [the metaanalysis of] Chard and al.
(2009), the current research literature on repeated reading is not sufficient for it to be designated as
an evidence-based practice. (Lo, Cooke, & Starling, 2011, pp. 133, 136)
Explanation. An early section of the discussion needs to provide a clear and concise summary of
the findings of the study, including the strength of the intervention effect and the clinical importance
of the findings. The results should be interpreted in terms that are specific to the study, as well as more
generally with reference to the current literature. Interpretation specific to the study will benefit from
taking into account the aims of the study, along with the robustness of methodology and procedures.
Item 23 on limitations of the study is a separate item in the SCRIBE 2016 Statement, but has obvious
rele- vance to the item on interpretation.
Vandenbroucke et al. (2007) note that overinterpretation is a common problem in observational
studies. For the STROBE Statement, they advocate that caution is exercised in interpreting the findings
of a study. A cautious approach to interpretation is particularly pertinent to SCEDs in instances where
findings are unclear or adequate replication has not occurred (see Item 7).
In terms of interpreting the study findings in the context of the current evidence from the literature,
the CONSORT Statement (Schulz et al., 2010) suggests that results of clinical trials are inter- preted with
respect to the knowledge base, as synthesized in system- atic reviews. In some research areas using
142 R.L. Tate et al. / Pratiques psychologiques 25 (2019) 119–151
SCEDs, meta-analyses are available and it is recommended that information from these be incorporated
when available (as in the above example of Lo, Cooke, & Starling, 2011, referring to the meta-analysis
of Chard, Ketterlin-Geller, Baker, Doabler, & Apichatabutra, 2009).
Item 23—Limitations: Discuss limitations, addressing sources of potential bias and imprecision.
Example.
The validity of comparisons between AFT [Alliance Focused Treatment] and BCT [Behavioral Change
Treatment] was compromised by several factors, including the significant intervention interruptions
during BCT, the administration of psychotropic medication during the study. Furthermore, there may
have been significant carry-over effects from one phase to another, as skills learned during one phase
could not be “un- learned”. Limitations to measurement include possible limitation to the accuracy
of the self-report nature of the kilocalorie intake, which was not verified by other sources of data
collection (e.g., independent observa- tion). (Satir et al., 2011, p. 417)
Explanation. It is often tempting for authors to focus on the positive findings of their results and to
glide over the flaws in their study. However, all studies have limitations that can either bias or confound
results. Important limitations reflect threats to the validity of the study that introduce potential bias
in the findings.
There are many potential limitations in SCED studies that compro- mise the extent to which results
are unbiased, reliable and likely to generalize (e.g., see Horner et al., 2005; Tate et al., 2013b; Wolery,
Dunlap & Ledford, 2011). These limitations include the following: (a) poor matching of the design to the
type of intervention (see Item 5); inadequate replication (see Items 7 and 24); (c) absence of blind- ing
(see Item 9); (d) lack of randomization (see Item 8); (e) impreci- sion with respect to the description of
the participant’s functional abilities (and, where applicable, diagnosis), making it difficult for readers
to generalize to other cases (see Items 10 and 11); (f) problems with the operational definition of the
target behavior or assessment of its reliability, insufficient number of data points in some or all of the
phases to meet minimum standards (see Item 14); (g) absence of information regarding procedural
fidelity (see Item 17); and (h) reli- ance on visual analysis for ambiguous cases, insufficient number
of data points required for specific statistical analyses (e.g., the C sta- tistic requires at least eight data
points per phase), use of statistical procedures that do not deal adequately with extant features of the
data (e.g., trend, variability or auto-correlation), or whose underlying as- sumptions are not met  (see
Item 18).
In terms of adequate reporting, authors need to provide a systematic
discussion of specific limitations associated with their findings (as de- scribed above) which is
also contextualized within the relevant literature. In this way the reader is provided with a realistic,
critical appraisal of the contribution that the study makes to the field and the extent to which the
results reflect a strong finding that is likely to be repeated.
Item 24 —Applicability: Discuss applicability and implications of the study findings.
Example.
The results of the present study replicate the findings of [ref] with regard to the effect of using DRA
[differential reinforcement of alternative
behavior], nonremoval of the fork, and stimulus fading to increase variety of food intake. The study
extends previous findings by showing that the intervention package was  effective independent of who
fed the child.
The effect of our treatment on John’s consumption of nonpreferred foods did not generalize across
settings in the absence of intervention in the home, but multisetting training led to transfer across
settings and caregivers. Our study also shows that the treatment package described by [ref] was effec-
tive during typically occurring mealtimes with regularly scheduled food types, and that the treatment
was effective for increasing the number and variety of originally nonpreferred foods. (Valdimarsdóttir,
Halldorsdottir, & SigurÐardóttir, 2010, p. 105)
Explanation. The concept of applicability or generality is based on the assumption that inferences
can be drawn from the condition in which an intervention effect was  demonstrated, to other conditions
based on known similarities and differences be- tween these conditions (Gast, 2010a).
The reader should be provided with a discussion of implications of (a) conceptual/theoretical
considerations, (b) clinical/practical consid- erations, and (c) methodological considerations, which
impact on the generalizability of the findings. Conclusions could be drawn, for example, from infor-
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mation provided about replication (Item 7), inclu- sion and exclusion criteria (Item 10), participant
characteristics (Item 11), and generalization measures (Item 14).
The replication process (see also Item 7) involves an increasing number of variations to the different
dimensions (most importantly participants, setting and practitioner) that can be changed with every
replication (Barlow et al., 2009; Sidman, 1960). Each replication will add information regarding the
generalizability of the findings. The stage of the replication process (direct or systematic; see, e.g., Gast,
2010a) should be made clear. Similarities and differences between the current and previous studies
need to be explicated.
Reference should be made to factors that determined baseline performance, such as described in
Items 10 and 11, because these factors are hypothesized to influence relations between the indepen-
dent variable and the dependent variable in a very specific way  (Horner et al., 2005; Wolery et al., 2011).
If outcome measures additional to the target behavior (Item 14) are used for the purpose of gener-
alization, authors should discuss the evidence to support (or not) a functional relationship between
the independent variable and the gener- alization variable in the context of a theoretical framework,
if available. If responses to the intervention differed across participants (or between studies), reasons
and proposed causal relationships of this finding should be discussed and new propositions made to
explain the finding.
Section 6: Documentation—Protocol, Funding (Items 25–26)
Item 25—Protocol: If available, state where a study protocol can be accessed. No published
SCED studies were identified that contained information on how to access a protocol. A number of
published reports indicated that the research protocol of a SCED was reviewed by an institutional
research committee, but this pertains to Item 13. Several SCED protocols were identified in trial reg-
istries (Lloyd at www.anzctr.org.au, Trial ID ACTRN12611000812998; Pool at www.anzctr.org.au, Trial
ID ACTRN12611000531910; Wambaugh, Mauszycki, Cameron, Wright, & Nessler, 2013; Wambaugh,
Nessler, & Wright, 2013, at www.clinicaltrials.gov) but personal communication with the authors indi-
cated that the studies were not yet published (Lloyd & Sherrington, 2011) or the published report did
not make reference to the protocol (Pool, Blackmore, Bear, & Valentine, 2014; Wambaugh et al., 2013a,
b).
Explanation. Trial protocol availability was a new item introduced for the CONSORT 2010 State-
ment (Schulz et al., 2010) and is also included in the CENT 2015 Statement (Shamseer et al., 2015;
Vohra et al., 2015). Moher et al. 2010a, p. 21 indicate that the protocol refers to the planned methods
of the “complete trial (rather than a protocol of a specific procedure within a trial).” The rationale
for including the protocol item in the CONSORT 2010 Statement was based on published evidence
of the discrepancy between the trial protocol and the subsequent published report (e.g., selective
reporting of results, post hoc change in the main outcome measure). Such discrepancies continue to
be documented (Dwan et al., 2011).
Having a protocol readily accessible makes authors accountable for any changes that are made to
the planned research design and analysis. As noted, however, a special feature of SCED methodology
is its flexibility in terms of modifying the design and/or intervention after the trial has commenced
(e.g., if the participant does not respond to intervention or specific research problems arise). These
modifications do not necessarily compromise the experiment (Connell & Thompson, 1986; Gravetter
& Forzano, 2009). As a consequence, in a SCED the design and/or intervention actually received may
depart from an a priori protocol. Such departure is considered acceptable within SCED methodology,
as long as the authors declare such departure and provide justification for it (see Item 6). Nonetheless,
the flexibility to modify the design and intervention in SCEDs does not imply that an a priori protocol
is not relevant.
The SPIRIT 2013 Statement (Standard Protocol Items: Recommen- dations for Interventional Trials;
Chan et al., 2013) provides guidance for the report of protocols of clinical trials and can be used as
a guide for preparing a protocol on a SCED study. As noted in the CONSORT 2010 Explanation and
Elaboration document (Moher et al., 2010a), there are many ways in which a protocol can be made
available, including trial registries, journals that publish protocols, website of the journal publishing
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the main results of the study, author’s institu- tional website, contact with the author. Reference to
the study proto- col can be made either in the text or as a footnote.
Item 26 —Funding: Identify source/s of funding and other sup- port; describe the role of funders.
Example.
Funding.
The study was financed by the Sint Maartenskliniek Nijmegen and Woerden, the Netherlands.
Competing interests.
All authors declare: no support from any organisation for the submitted work, no financial rela-
tionships with any organisations that might have an interest in the submitted work in the previous
3 years and no other relationships or activities that could appear to have influenced the submitted
work. (Hoogeboom et al., 2012, p. 8)
Explanation. Journals often request that authors disclose funding sources. It is important that
readers of the manuscript can make a judgment as to whether the funders have control over knowl-
edge dissemination or whether they provided funds but the researchers worked independently and
autonomously. A consistently and overwhelmingly strong association between industry support and
proindustry findings in group clinical trials has been demonstrated (Sismondo, 2008a, 2008b). The like-
lihood of finding a positive result when backed by industry funding has been estimated in the range
of 3.6 to 4.05 times greater than when not (Bekelman, Li, & Gross, 2003; Lexchin, Bero, Djulbegovic,
& Clark, 2003). Although methodological quality is not necessarily compromised in industry-funded
research (Sismondo, 2008a), bias may  infiltrate in other ways such as the decision to use less active
controls (Bekelman et al., 2003).
Provision of a grant number can be helpful because it enables readers to retrieve the details of the
grant. Otherwise, one needs to know the following: Did the funder provide equipment or money? Did
the funder have control over where the study was published or what was published? Were the funders
the authors, or did they edit the manu- script? Any conflicts of interest should be stated explicitly.
This information can be provided in the body of the text or in a footnote.
Conclusion
We  developed the SCRIBE 2016 to assist investigators in the behavioral sciences to report SCEDs
with transparency, accuracy, clarity and completeness. This article provides rationale for and ex-
planation of the 26 SCRIBE 2016 items. It also includes examples of adequate reporting of specific
SCRIBE 2016 items, drawing on arti- cles in the published literature. Authors reporting on one specific
type of single-case methodology, the medical N-of-1 trial with multiple cross-overs, will find it helpful
to consult the CENT 2015 Statement (Shamseer et al., 2015; Vohra et al., 2015), which was  developed
for that particular methodology. We  welcome feedback from users of the SCRIBE 2016, which can be
made through the SCRIBE website (www.sydney.edu.au/medicine/research/scribe).
Since the first CONSORT guideline appeared in 1996 (Begg et al., 1996), medical journals have
continued advocating the use of pre- scriptive reporting guidelines in the CONSORT tradition. The
EQUATOR network (www.equator-network.org) is a useful resource to keep up-to-date with new
developments in this field. This develop- ment has not occurred in the behavioral sciences to the same
degree, although many authors of intervention studies in the behavioral sciences consult relevant
CONSORT Statements (e.g., CONSORT Extension to Nonpharmacological Interventions; Boutron et al.,
2008). The influence of CONSORT is such that the peak medical journals require that authors address all
of the criteria of the relevant guideline in their report. The benefit has resulted in improved reporting
(Turner et al., 2012). It will be advantageous to the behavioral sciences if journals publishing single-case
methodology also endorse use of the SCRIBE 2016 in this way.
Uncited references
Shadish et al., 2014; Wilcoxin, 1947.
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Appendix A. Appendix A Selection of Data Analysis Methods Applicable to SCEDs
For a comprehensive discussion of statistical techniques in SCEDs, see Kazdin (2011).
Visual Analysis
Guidelines for systematic analysis (Kratochwill et al., 2010)
Software for visual analysis (Bulté & Onghena, 2012)
Quasistatistical Techniques
Split-middle trend line (Kazdin, 1982a; White & Haring, 1980)
Binomial distribution test (Siegel & Castellan, 1988)
Standard deviation band (Bloom & Fischer, 1982; Krishef, 1991)
Time Series Analysis
C statistic (DeCarlo & Tryon, 1993; Tryon, 1982)
Auto-regressive integrated moving average (Box & Jenkins, 1970; Gottman & Glass, 1978)
“Traditional” Inferential Statistics Tests Parametric.t Test (Student, 1908)
F Test (Fisher, 1920)
Nonparametric.
Wilcoxon matched-pairs signed-ranks test (Wilcoxon, 1947)
Friedman two-way analysis of variance (Friedman, 1937)
Effect Sizes
For reviews, see Alresheed, Hott, and Bano (2013); Beretvas and Chung (2008); Shadish, Rindskopf,
and Hedges (2008):
Trend analysis effect size (Gorsuch, 1983)
Improvement rate difference (Parker, Vannest, & Brown, 2009)
Nonoverlap of all pairs* (Parker & Vannest, 2009)
Percentage of nonoverlapping data* (Scruggs & Mastropieri, 2013; Scruggs, Mastropieri, & Casto,
1987)
Tau-U (Parker, Vannest, David & Sauber, 2011)
Bayesian probability model
Mean-shift and mean-plus trend models (Allison & Gorman, 1993; Center, Skiba, & Casey, 1985)d
Statistic (Hedges, Pustejovsky, & Shadish, 2013; Shadish, 2014)
Multilevel linear modelling (Swaminathan, Rogers, Horner, Sugai, & Smolkowski, 2014)
Randomization Tests (Edgington, 1980, 1996; Ferron & Onghena, 1996; Ferron & Ware, 1994;
Onghena & Edgington, 2005)
For more information on nonoverlap methods, see Parker, Vannest, and Davis (2014).
Appendix B. Supplementary data
Supplementary data associated with this article can be found, in the online version, at
https://doi.org/10.1016/j.prps.2019.03.001.
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